Drug companies would have to maintain three months of safety stock in Canada for medicines that are critical and vulnerable to shortage if new proposals for addressing medicine shortages in the country are adopted.
Canada Proposes New Obligations to Tackle Worsening Drug Shortages Problem
A new requirement for drug companies on how much safety stock to maintain and a mechanism for extending the expiration date of a lot or batch of a drug if there is a shortage that could cause harm are among the measures Health Canada is proposing to adopt.
More from Distribution/Supply Chain
• By
The rollout of Trump’s plan has been a policy whiplash, but despite a 90-day pause on tariffs, the US president still appears to be holding a grudge with industry over drug pricing.
• By
Sector-specific tariffs, including on pharmaceuticals, could be announced as early as this week.
• By
Amid ongoing generic drug supply problems, Japan's government is to set up a new fund to support corporate investments geared towards manufacturing and consolidation.
• By
Newly proposed legislation for bolstering the EU’s drug manufacturing capacity and reducing its overreliance on foreign manufacturers includes a number of measures, such as a requirement for EU countries to prioritize the security of supply over price when procuring drugs.